<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anticardiolipin antibodies have recently been described in association with arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and with neurological symptoms, in <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In a study of 70 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's syndrome 13 patients had these antibodies </plain></SENT>
<SENT sid="2" pm="."><plain>Of these 13 patients eight had a history of either <z:chebi fb="46" ids="15035">retinal</z:chebi> vascular pathology, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, or <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The association of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and the presence of anticardiolipin antibodies was statistically significant </plain></SENT>
</text></document>